Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Century Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 56 | 54 | −2 |
| Shares | 21.8M | 21.1M | −659.1K (−3.0%) |
| Value | $182.8M | $208.7M | +$25.9M (+14.2%) |
New holders (8)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 370,587 | $3.67M | 0.02% |
| Kettle Hill Capital Management, LLC | 54,100 | $535.0K | 0.13% |
| Dimensional Fund Advisors LP | 37,440 | $370.0K | 0.00% |
| Trexquant Investment LP | 24,606 | $243.0K | 0.01% |
| Nisa Investment Advisors, LLC | 12,000 | $126.0K | 0.00% |
| Walleye Trading LLC | 12,385 | $122.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 551 | $5.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 34 | $0 | 0.00% |
Sold out (10)
Institutions that held Century Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 756,821 | $6.36M |
| Woodline Partners LP | 208,082 | $1.75M |
| Citadel Advisors LLC | 59,966 | $504.0K |
| Susquehanna International Group, LLP | 14,152 | $119.0K |
| Delphia (USA) Inc. | 10,548 | $89.0K |
| Hershey Trust Co | 4,723 | $40.0K |
| National Bank of Canada | 2,500 | $21.0K |
| Point72 Hong Kong Ltd | 186 | $2.00K |
| Patriot Financial Group Insurance Agency, LLC | 65 | $1.00K |
| Captrust Financial Advisors | 19 | $0 |